CheMyong Ko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
CheMyong Ko has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
Po-Ching Lin
Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA
10 shared publicationsChan Jin Park
Epivara, Inc. , 2109 S. Oak Street, Suite 100A, Champaign, IL 61820
9 shared publications- Radwa Barakat
Department of Genetics, Development and Cell Biology; Iowa State University, Ames, USA
8 shared publications - Joseph A. Cacioppo
Comparative Biosciences, College of Veterinary Medicine, University of Illinois, Urbana-Campaign, Illinois
7 shared publications Po-Ching Patrick Lin
Department of Comparative Biosciences, The University of Illinois at Urbana-Champaign , 2001 South Lincoln Avenue, Urbana, IL 61802
7 shared publicationsRadwa Barakat
Department of Comparative Biosciences , College of Veterinary Medicine Urbana, IL , USA
7 shared publications
Latest Publications
- 7 May 2026
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 115 (2) , 550-564
Estrogen receptor expression in GnRH neurons: back to the future
Estrogen feedback within the hypothalamic–pituitary–gonadal axis is mediated primarily by upstream estrogen-sensitive neuronal populations, most notably kisspeptin neurons, which translate circulating sex steroid levels into excitatory or inhibitory input to gonadotropin-releasing hormone (GnRH) neurons, the final neural output controlling pituitary gonadotropin secretion. Despite extensive research, the expression and role of estrogen receptors in GnRH neurons remain poorly understood. To systematically evaluate what can be inferred from transcriptomic data alone, we conducted a comprehensive analysis of open-source single-cell and single-nucleus RNA-sequencing (sc/snRNA-seq) datasets encompassing mouse embryogenesis through adulthood, supplemented by cross-species datasets from rat, squirrel, pig, and human hypothalami. In adult mice, Esr1 transcripts were detected in a distinct subset of Gnrh1+ cells more frequently than Esr2 transcripts. Notably, this expression was dynamic, with an increased proportion of Esr1+Gnrh1+ cells emerging during maturation, particularly after puberty. In contrast, Esr2 detection remained minimal across developmental stages. Pseudotime analysis showed Esr1+Gnrh1+ cells at late pseudotime, coinciding with advanced maturation states. Cross-species comparisons further revealed species-specific patterns, with Esr1+Gnrh1+ cells consistently more prevalent than Esr2+Gnrh1+ cells in rodents, while ESR2+GNRH1+ cells were slightly more detectable in pigs and humans. These results support a model where estrogen signaling within GnRH neurons is heterogeneous, developmentally regulated, and often mediated indirectly through upstream estrogen-sensitive circuits, such as kisspeptin and nitric oxide synthase neurons. This study provides a comprehensive, unbiased transcriptomic framework for understanding estrogen receptor expression in GnRH neurons, offering new insights into how estrogen might influence reproductive function through both direct and indirect signaling pathways.
- 7 May 2026
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 115 (2) , 550-564
Estrogen receptor expression in GnRH neurons: back to the future
Estrogen feedback within the hypothalamic–pituitary–gonadal axis is mediated primarily by upstream estrogen-sensitive neuronal populations, most notably kisspeptin neurons, which translate circulating sex steroid levels into excitatory or inhibitory input to gonadotropin-releasing hormone (GnRH) neurons, the final neural output controlling pituitary gonadotropin secretion. Despite extensive research, the expression and role of estrogen receptors in GnRH neurons remain poorly understood. To systematically evaluate what can be inferred from transcriptomic data alone, we conducted a comprehensive analysis of open-source single-cell and single-nucleus RNA-sequencing (sc/snRNA-seq) datasets encompassing mouse embryogenesis through adulthood, supplemented by cross-species datasets from rat, squirrel, pig, and human hypothalami. In adult mice, Esr1 transcripts were detected in a distinct subset of Gnrh1+ cells more frequently than Esr2 transcripts. Notably, this expression was dynamic, with an increased proportion of Esr1+Gnrh1+ cells emerging during maturation, particularly after puberty. In contrast, Esr2 detection remained minimal across developmental stages. Pseudotime analysis showed Esr1+Gnrh1+ cells at late pseudotime, coinciding with advanced maturation states. Cross-species comparisons further revealed species-specific patterns, with Esr1+Gnrh1+ cells consistently more prevalent than Esr2+Gnrh1+ cells in rodents, while ESR2+GNRH1+ cells were slightly more detectable in pigs and humans. These results support a model where estrogen signaling within GnRH neurons is heterogeneous, developmentally regulated, and often mediated indirectly through upstream estrogen-sensitive circuits, such as kisspeptin and nitric oxide synthase neurons. This study provides a comprehensive, unbiased transcriptomic framework for understanding estrogen receptor expression in GnRH neurons, offering new insights into how estrogen might influence reproductive function through both direct and indirect signaling pathways.
- 6 August 2025
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 113 (5) , 1196-1208
Conditional ablation of Insr and Igf1r using Esr2 -Cre leads to abnormal ovarian follicle development and infertility in mice
Conditional ablation of Igf1r in early folliculogenesis has demonstrated the necessity of insulin signaling to progress to the antral stage, whereas ablation of both Insr and Igfr1 in the periovulatory window allows the formation of the antrum but reduces the efficiency of ovulation and subsequent luteinization. For this study, we examined the independent and shared actions in single and double knockouts (DKO) for Insr and Ifg1r using Esr2-Cre. As this recombinase is active during neonatal ovarian development and the initial wave of folliculogenesis, we hypothesized that abnormalities in ovary formation and establishment of the initial follicle pool would occur, which could alter female reproductive lifespan. We found that ablation of both receptors led to a delay in puberty, altered mating frequency, and ultimately infertility for Igf1rd/d and DKO females. Quantitation of germ cell cyst breakdown, and formation of primordial and primary follicles were normal in the neonatal window and at puberty, suggesting insulin signaling was not essential for establishment of ovarian reserve. However, the loss of IGF1R signaling impaired transition from primary to secondary follicles, which was worsened when IGF ligand cross-reactivity from INSR signaling was lost in DKO mice. DKO mice also exhibited abnormal follicle activation in the absence of hormone stimulation, but no subsequent proliferation of granulosa cells or antrum formation occurred. In adult mice, loss of either receptor disrupted estrous cyclicity, with DKO mice rarely leaving metestrus indicating abnormal regulation of the HPG axis contributing to subfertility and infertility observed in single and double receptor knockouts.
- 6 August 2025
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 113 (5) , 1196-1208
Conditional ablation of Insr and Igf1r using Esr2 -Cre leads to abnormal ovarian follicle development and infertility in mice
Conditional ablation of Igf1r in early folliculogenesis has demonstrated the necessity of insulin signaling to progress to the antral stage, whereas ablation of both Insr and Igfr1 in the periovulatory window allows the formation of the antrum but reduces the efficiency of ovulation and subsequent luteinization. For this study, we examined the independent and shared actions in single and double knockouts (DKO) for Insr and Ifg1r using Esr2-Cre. As this recombinase is active during neonatal ovarian development and the initial wave of folliculogenesis, we hypothesized that abnormalities in ovary formation and establishment of the initial follicle pool would occur, which could alter female reproductive lifespan. We found that ablation of both receptors led to a delay in puberty, altered mating frequency, and ultimately infertility for Igf1rd/d and DKO females. Quantitation of germ cell cyst breakdown, and formation of primordial and primary follicles were normal in the neonatal window and at puberty, suggesting insulin signaling was not essential for establishment of ovarian reserve. However, the loss of IGF1R signaling impaired transition from primary to secondary follicles, which was worsened when IGF ligand cross-reactivity from INSR signaling was lost in DKO mice. DKO mice also exhibited abnormal follicle activation in the absence of hormone stimulation, but no subsequent proliferation of granulosa cells or antrum formation occurred. In adult mice, loss of either receptor disrupted estrous cyclicity, with DKO mice rarely leaving metestrus indicating abnormal regulation of the HPG axis contributing to subfertility and infertility observed in single and double receptor knockouts.
- 13 February 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (4) , e70388
Granulosa cell expression of Fos is critical for regulating ovulatory gene expressions in the mouse ovary
A previous study showed that female Fos null mice fail to ovulate even when given gonadotropins, suggesting that ovarian expression of Fos is critical for successful ovulation. However, the expression of FOS and function of FOS have not been determined in the mouse ovary. FOS, a member of the Fos family ( Fos, Fosb, Fosl1 , and Fosl2 ), functions as a transcription factor by forming a heterodimer complex with a member of Jun family ( Jun, Junb , and Jund ). This study demonstrated rapid increases in Fos , along with other Fos and Jun family members, after hCG administration in the ovary of immature PMSG‐primed mice and after the LH surge in naturally cycling animals. ChIP‐seq analysis identified 1965 FOS‐binding genes in granulosa cells collected at 3 h post‐hCG, including Pgr , Ptgs2, Tnfiap6 , and Edn2 , genes known to be involved in the ovulatory process. When super‐ovulation was induced, the number of oocytes released was significantly reduced in Esr2 cre/+ ‐driven granulosa cell‐specific Fos knockout ( gcFos KO) mice. This reduction was accompanied by lower expressions of Pgr, Ptgs2, Ptgs1, and Edn2 in preovulatory follicles of gcFosKO mice compared to those in control littermates. In addition, gcFos KO mice showed a trend toward a decreased average litter size. Together, the present study indicates that the preovulatory induction of Fos expression is crucial for increasing the expression of key ovulatory genes, yet the role of FOS may be partially substituted by other Fos and Jun family members induced in the preovulatory follicle in the gcFos KO mouse ovary.
- 13 February 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (4) , e70388
Granulosa cell expression of Fos is critical for regulating ovulatory gene expressions in the mouse ovary
A previous study showed that female Fos null mice fail to ovulate even when given gonadotropins, suggesting that ovarian expression of Fos is critical for successful ovulation. However, the expression of FOS and function of FOS have not been determined in the mouse ovary. FOS, a member of the Fos family ( Fos, Fosb, Fosl1 , and Fosl2 ), functions as a transcription factor by forming a heterodimer complex with a member of Jun family ( Jun, Junb , and Jund ). This study demonstrated rapid increases in Fos , along with other Fos and Jun family members, after hCG administration in the ovary of immature PMSG‐primed mice and after the LH surge in naturally cycling animals. ChIP‐seq analysis identified 1965 FOS‐binding genes in granulosa cells collected at 3 h post‐hCG, including Pgr , Ptgs2, Tnfiap6 , and Edn2 , genes known to be involved in the ovulatory process. When super‐ovulation was induced, the number of oocytes released was significantly reduced in Esr2 cre/+ ‐driven granulosa cell‐specific Fos knockout ( gcFos KO) mice. This reduction was accompanied by lower expressions of Pgr, Ptgs2, Ptgs1, and Edn2 in preovulatory follicles of gcFosKO mice compared to those in control littermates. In addition, gcFos KO mice showed a trend toward a decreased average litter size. Together, the present study indicates that the preovulatory induction of Fos expression is crucial for increasing the expression of key ovulatory genes, yet the role of FOS may be partially substituted by other Fos and Jun family members induced in the preovulatory follicle in the gcFos KO mouse ovary.
- 6 January 2025
- Published by The Endocrine Society in Endocrinology
- Vol. 166 (2)
A Dynamic Shift in Estrogen Receptor Expression During Granulosa Cell Differentiation in the Ovary
This study uncovers a dynamic shift in estrogen receptor expression during granulosa cell (GC) differentiation in the ovary, highlighting a transition from estrogen receptor alpha (ESR1) to estrogen receptor beta (ESR2). Using a transgenic mouse model with Esr1-iCre-mediated Esr2 deletion, we demonstrate that ESR2 expression is absent in GCs derived from ESR1-expressing ovarian surface epithelium (OSE) cells. Single-cell analysis of the OSE-GC lineage reveals a developmental trajectory from Esr1-expressing OSE cells to Foxl2-expressing pre-GCs, culminating in GCs exclusively expressing Esr2. Transcriptome analyses identified vasculature-derived TGFβ1 ligands as key regulators of this transition. Supporting this, TGFβ1 treatment of cultured embryonic ovaries reduced Esr1 expression while promoting Esr2 expression. This study underscores the capability of GCs to switch from ESR1 to ESR2 expression as a fundamental aspect of normal differentiation.
- 6 January 2025
- Published by The Endocrine Society in Endocrinology
- Vol. 166 (2)
A Dynamic Shift in Estrogen Receptor Expression During Granulosa Cell Differentiation in the Ovary
This study uncovers a dynamic shift in estrogen receptor expression during granulosa cell (GC) differentiation in the ovary, highlighting a transition from estrogen receptor alpha (ESR1) to estrogen receptor beta (ESR2). Using a transgenic mouse model with Esr1-iCre-mediated Esr2 deletion, we demonstrate that ESR2 expression is absent in GCs derived from ESR1-expressing ovarian surface epithelium (OSE) cells. Single-cell analysis of the OSE-GC lineage reveals a developmental trajectory from Esr1-expressing OSE cells to Foxl2-expressing pre-GCs, culminating in GCs exclusively expressing Esr2. Transcriptome analyses identified vasculature-derived TGFβ1 ligands as key regulators of this transition. Supporting this, TGFβ1 treatment of cultured embryonic ovaries reduced Esr1 expression while promoting Esr2 expression. This study underscores the capability of GCs to switch from ESR1 to ESR2 expression as a fundamental aspect of normal differentiation.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Animal Reproduction
- Vol. 22 (1) , e20240080
Absence of mating behaviors in the female dogs neonatally treated with estrogen and progesterone
This study aimed to develop a non-surgical method to neutralize reproduction in female dogs. Female Beagle puppies, aged 6 days, were treated with pellets designed to release estradiol benzoate (EB; 1.0 mg) and progesterone (P4; 5.0 mg) over approximately 3 weeks. Their estrous cycles were monitored from 6 to 34 months of age by examining their vulvas daily and measuring their serum P4 levels once a month. Vulvar edema and discharge, followed by a serum P4 level above 5 ng/ml, indicated the potential estrus. Each time a dog showed these signs, breeding was attempted by housing with a proven male Beagle. All the treated dogs displayed cyclic progesterone surges with 5 to 6-month-long anestrous intervals. Surprisingly, none exhibited sexual behaviors, and no mating occurred (i.e., no intromission and copulatory tie), resulting in no pups being born. This phenomenon was further explored in laboratory animals. Neonatal female rats were treated with microspheres containing smaller doses of the same steroids (0.3 mg EB + 3.0 mg P4) at 1 or 2 days old. At 3 months old, the rats were ovariectomized, chemically stimulated to exhibit estrus behaviors using a standard protocol and tested for receptivity to proven male rats. Untreated control rats showed normal receptivity (i.e., lordosis) and allowed males to mate. However, rats treated with EB+P4 did not exhibit lordosis or allow mating. These results indicate that the combined use of estrogen and progesterone could be an effective non-surgical method for inhibiting mating behavior and, consequently, neutralizing female dog reproduction.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Animal Reproduction
- Vol. 22 (1) , e20240080
Open AccessAbsence of mating behaviors in the female dogs neonatally treated with estrogen and progesterone
This study aimed to develop a non-surgical method to neutralize reproduction in female dogs. Female Beagle puppies, aged 6 days, were treated with pellets designed to release estradiol benzoate (EB; 1.0 mg) and progesterone (P4; 5.0 mg) over approximately 3 weeks. Their estrous cycles were monitored from 6 to 34 months of age by examining their vulvas daily and measuring their serum P4 levels once a month. Vulvar edema and discharge, followed by a serum P4 level above 5 ng/ml, indicated the potential estrus. Each time a dog showed these signs, breeding was attempted by housing with a proven male Beagle. All the treated dogs displayed cyclic progesterone surges with 5 to 6-month-long anestrous intervals. Surprisingly, none exhibited sexual behaviors, and no mating occurred (i.e., no intromission and copulatory tie), resulting in no pups being born. This phenomenon was further explored in laboratory animals. Neonatal female rats were treated with microspheres containing smaller doses of the same steroids (0.3 mg EB + 3.0 mg P4) at 1 or 2 days old. At 3 months old, the rats were ovariectomized, chemically stimulated to exhibit estrus behaviors using a standard protocol and tested for receptivity to proven male rats. Untreated control rats showed normal receptivity (i.e., lordosis) and allowed males to mate. However, rats treated with EB+P4 did not exhibit lordosis or allow mating. These results indicate that the combined use of estrogen and progesterone could be an effective non-surgical method for inhibiting mating behavior and, consequently, neutralizing female dog reproduction.
- Open Access
- 23 December 2024
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 4 (1) , pgaf010
Decreased lymph node estrogen levels cause nonremitting progressive experimental autoimmune encephalomyelitis disease
Estrogen, a steroid hormone synthesized by both gonadal and nongonadal tissues, plays a pivotal role in modulating immune responses, including reducing relapse rates in relapsing–remitting multiple sclerosis (MS). This study explored the expression of aromatase, the enzyme responsible for estrogen synthesis, in lymph nodes (LNs) and its potential role in the pathogenesis of MS using a mouse model. We utilized Cyp19-RFP mice where cells that express or have previously expressed the Cyp19 gene (encoding aromatase) are marked by red fluorescent protein (RFP). RFP was detected in the high endothelial venules of all morphologically identifiable LNs, indicating aromatase activity within these tissues. We discovered that LNs actively synthesize 17β-estradiol, but this activity declines with age. Targeted delivery of an aromatase inhibitor specifically to LNs induced an interferon-β-resistant experimental autoimmune encephalomyelitis (EAE) phenotype. This phenotype was accompanied by significant gray matter atrophy in the spinal cord. These findings underscore LNs as crucial sites of de novo 17β-estradiol production, potentially contributing to nonremitting EAE phenotypes. The observed decline in 17β-estradiol likely exacerbates MS pathogenesis in aging mice. Importantly, aromatase expression in human cervical LNs suggests that these sites may similarly contribute to estrogen synthesis in humans, potentially opening new avenues for understanding and treating MS.
- 23 December 2024
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 4 (1) , pgaf010
Open AccessDecreased lymph node estrogen levels cause nonremitting progressive experimental autoimmune encephalomyelitis disease
Estrogen, a steroid hormone synthesized by both gonadal and nongonadal tissues, plays a pivotal role in modulating immune responses, including reducing relapse rates in relapsing–remitting multiple sclerosis (MS). This study explored the expression of aromatase, the enzyme responsible for estrogen synthesis, in lymph nodes (LNs) and its potential role in the pathogenesis of MS using a mouse model. We utilized Cyp19-RFP mice where cells that express or have previously expressed the Cyp19 gene (encoding aromatase) are marked by red fluorescent protein (RFP). RFP was detected in the high endothelial venules of all morphologically identifiable LNs, indicating aromatase activity within these tissues. We discovered that LNs actively synthesize 17β-estradiol, but this activity declines with age. Targeted delivery of an aromatase inhibitor specifically to LNs induced an interferon-β-resistant experimental autoimmune encephalomyelitis (EAE) phenotype. This phenotype was accompanied by significant gray matter atrophy in the spinal cord. These findings underscore LNs as crucial sites of de novo 17β-estradiol production, potentially contributing to nonremitting EAE phenotypes. The observed decline in 17β-estradiol likely exacerbates MS pathogenesis in aging mice. Importantly, aromatase expression in human cervical LNs suggests that these sites may similarly contribute to estrogen synthesis in humans, potentially opening new avenues for understanding and treating MS.
- Open Access
- 27 September 2024
- Published by Elsevier in Animal Reproduction Science
- Vol. 270, 107606
Inhibition of testicular development by suppressing neonatal LH rise in male domestic pigs
- 27 September 2024
- Published by Elsevier in Animal Reproduction Science
- Vol. 270, 107606
Open AccessInhibition of testicular development by suppressing neonatal LH rise in male domestic pigs
- 13 May 2024
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 111 (2) , 269-291
Cryptorchidism and testicular cancer in the dog: unresolved questions and challenges in translating insights from human studies
Cryptorchidism, the failure of one or both testes to descend into the scrotum, and testicular cancer show a strong correlation in both dogs and humans. Yet, long-standing medical debates persist about whether the location of undescended testes directly causes testicular cancer in humans or if both conditions stem from a common origin. Although testicular cancer is a prevalent disease in dogs, even less is known about its cause and correlation with testicular descent in this species. This review investigates the relation between these two disorders in dogs, drawing insights from human studies, and examines key biomarkers identified thus far. In addition, it explores potential causal links, including the impact of temperature on maturing testicular cells and a potential shared genetic origin. Notably, this literature review reveals significant differences between men and dogs in reproductive development, histological and molecular features of testicular tumors, and the prevalence of specific tumor types, such as Sertoli cell tumors in cryptorchid dogs and germ cell tumors in humans. These disparities caution against using dogs as models for human testicular cancer research and underscore the limitations when drawing comparisons between species. The paper concludes by suggesting specific research initiatives to enhance our understanding of the complex interplay between cryptorchidism and testicular cancer in dogs.
- 13 May 2024
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 111 (2) , 269-291
Cryptorchidism and testicular cancer in the dog: unresolved questions and challenges in translating insights from human studies
Cryptorchidism, the failure of one or both testes to descend into the scrotum, and testicular cancer show a strong correlation in both dogs and humans. Yet, long-standing medical debates persist about whether the location of undescended testes directly causes testicular cancer in humans or if both conditions stem from a common origin. Although testicular cancer is a prevalent disease in dogs, even less is known about its cause and correlation with testicular descent in this species. This review investigates the relation between these two disorders in dogs, drawing insights from human studies, and examines key biomarkers identified thus far. In addition, it explores potential causal links, including the impact of temperature on maturing testicular cells and a potential shared genetic origin. Notably, this literature review reveals significant differences between men and dogs in reproductive development, histological and molecular features of testicular tumors, and the prevalence of specific tumor types, such as Sertoli cell tumors in cryptorchid dogs and germ cell tumors in humans. These disparities caution against using dogs as models for human testicular cancer research and underscore the limitations when drawing comparisons between species. The paper concludes by suggesting specific research initiatives to enhance our understanding of the complex interplay between cryptorchidism and testicular cancer in dogs.
- 21 February 2024
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 110 (5) , 1025-1037
Prenatal exposure to Di(2-ethylhexyl) phthalate and high-fat diet synergistically disrupts gonadal function in male mice
Prenatal exposure to Di(2-ethylhexyl) phthalate (DEHP) impairs the reproductive system and causes fertility defects in male offspring. Additionally, high-fat diet (HF) is a risk factor for reproductive disorders in males. In this study, we tested the hypothesis that prenatal exposure to a physiologically relevant dose of DEHP in conjunction with HF diet synergistically impacts reproductive function and fertility in male offspring. Female mice were fed a control or HF diet 7 days prior to mating and until their litters were weaned on postnatal day 21. Pregnant dams were exposed to DEHP (20 μg/kg/day) or vehicle from gestational day 10.5 until birth. The male offspring’s gross phenotype, sperm quality, serum hormonal levels, testicular histopathology, and testicular gene expression pattern were analyzed. Male mice born to dams exposed to DEHP + HF had smaller testes, epididymides, and shorter anogenital distance compared to those exposed to HF or DEHP alone. Sperm analysis revealed that DEHP+HF mice had lower sperm concentration and motility compared to DEHP mice. Moreover, DEHP+HF mice had more apoptotic germ cells, fewer Leydig cells, and lower serum testosterone levels than DEHP mice. Further, testicular mRNA expression of Dnmt1 and Dnmt3a was two to eight-fold higher than in DEHP mice by qPCR, suggesting that maternal HF diet and prenatal DEHP exposure additively impact gonadal function by altering the degree of DNA methylation in the testis. These results suggest that the combined exposure to DEHP and HF synergistically impairs reproductive function in male offspring, greater than exposure to DEHP or HF diet alone.
- 21 February 2024
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 110 (5) , 1025-1037
Prenatal exposure to Di(2-ethylhexyl) phthalate and high-fat diet synergistically disrupts gonadal function in male mice
Prenatal exposure to Di(2-ethylhexyl) phthalate (DEHP) impairs the reproductive system and causes fertility defects in male offspring. Additionally, high-fat diet (HF) is a risk factor for reproductive disorders in males. In this study, we tested the hypothesis that prenatal exposure to a physiologically relevant dose of DEHP in conjunction with HF diet synergistically impacts reproductive function and fertility in male offspring. Female mice were fed a control or HF diet 7 days prior to mating and until their litters were weaned on postnatal day 21. Pregnant dams were exposed to DEHP (20 μg/kg/day) or vehicle from gestational day 10.5 until birth. The male offspring’s gross phenotype, sperm quality, serum hormonal levels, testicular histopathology, and testicular gene expression pattern were analyzed. Male mice born to dams exposed to DEHP + HF had smaller testes, epididymides, and shorter anogenital distance compared to those exposed to HF or DEHP alone. Sperm analysis revealed that DEHP+HF mice had lower sperm concentration and motility compared to DEHP mice. Moreover, DEHP+HF mice had more apoptotic germ cells, fewer Leydig cells, and lower serum testosterone levels than DEHP mice. Further, testicular mRNA expression of Dnmt1 and Dnmt3a was two to eight-fold higher than in DEHP mice by qPCR, suggesting that maternal HF diet and prenatal DEHP exposure additively impact gonadal function by altering the degree of DNA methylation in the testis. These results suggest that the combined exposure to DEHP and HF synergistically impairs reproductive function in male offspring, greater than exposure to DEHP or HF diet alone.
- Open Access
- 14 June 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-20
Single neonatal estrogen implant sterilizes female animals by decreasing hypothalamic KISS1 expression
Reproductive sterilization by surgical gonadectomy is strongly advocated to help manage animal populations, especially domesticated pets, and to prevent reproductive behaviors and diseases. This study explored the use of a single-injection method to induce sterility in female animals as an alternative to surgical ovariohysterectomy. The idea was based on our recent finding that repetitive daily injection of estrogen into neonatal rats disrupted hypothalamic expression of Kisspeptin (KISS1), the neuropeptide that triggers and regulates pulsatile secretion of GnRH. Neonatal female rats were dosed with estradiol benzoate (EB) either by daily injections for 11 days or by subcutaneous implantation of an EB-containing silicone capsule designed to release EB over 2–3 weeks. Rats treated by either method did not exhibit estrous cyclicity, were anovulatory, and became infertile. The EB-treated rats had fewer hypothalamic Kisspeptin neurons, but the GnRH-LH axis remained responsive to Kisspeptin stimulation. Because it would be desirable to use a biodegradable carrier that is also easier to handle, an injectable EB carrier was developed from PLGA microspheres to provide pharmacokinetics comparable to the EB-containing silicone capsule. A single neonatal injection of EB-microspheres at an equivalent dosage resulted in sterility in the female rat. In neonatal female Beagle dogs, implantation of an EB-containing silicone capsule also reduced ovarian follicle development and significantly inhibited KISS1 expression in the hypothalamus. None of the treatments produced any concerning health effects, other than infertility. Therefore, further development of this technology for sterilization in domestic female animals, such as dogs and cats is worthy of investigation.
- 14 June 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-20
Open AccessSingle neonatal estrogen implant sterilizes female animals by decreasing hypothalamic KISS1 expression
Reproductive sterilization by surgical gonadectomy is strongly advocated to help manage animal populations, especially domesticated pets, and to prevent reproductive behaviors and diseases. This study explored the use of a single-injection method to induce sterility in female animals as an alternative to surgical ovariohysterectomy. The idea was based on our recent finding that repetitive daily injection of estrogen into neonatal rats disrupted hypothalamic expression of Kisspeptin (KISS1), the neuropeptide that triggers and regulates pulsatile secretion of GnRH. Neonatal female rats were dosed with estradiol benzoate (EB) either by daily injections for 11 days or by subcutaneous implantation of an EB-containing silicone capsule designed to release EB over 2–3 weeks. Rats treated by either method did not exhibit estrous cyclicity, were anovulatory, and became infertile. The EB-treated rats had fewer hypothalamic Kisspeptin neurons, but the GnRH-LH axis remained responsive to Kisspeptin stimulation. Because it would be desirable to use a biodegradable carrier that is also easier to handle, an injectable EB carrier was developed from PLGA microspheres to provide pharmacokinetics comparable to the EB-containing silicone capsule. A single neonatal injection of EB-microspheres at an equivalent dosage resulted in sterility in the female rat. In neonatal female Beagle dogs, implantation of an EB-containing silicone capsule also reduced ovarian follicle development and significantly inhibited KISS1 expression in the hypothalamus. None of the treatments produced any concerning health effects, other than infertility. Therefore, further development of this technology for sterilization in domestic female animals, such as dogs and cats is worthy of investigation.